A device that helps desperately sick patients breathe and costs just £150 ($212) to manufacture could revolutionize access to life-saving care in low to middle income countries.
Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, […]
One of the main reasons for the hold-ups in the mass vaccination campaigns against COVID-19 are the precautions that must be taken regarding the handling of […]
The ‘Xpert Ultra’ molecular test has a greater capacity than its predecessor (‘Xpert MTB/RIF’) in detecting tuberculosis cases, either passively (i.e. people who attend the hospital […]